1. Home
  2. EXEL vs WPP Comparison

EXEL vs WPP Comparison

Compare EXEL & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • WPP
  • Stock Information
  • Founded
  • EXEL 1994
  • WPP 1985
  • Country
  • EXEL United States
  • WPP United Kingdom
  • Employees
  • EXEL N/A
  • WPP N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • WPP Advertising
  • Sector
  • EXEL Health Care
  • WPP Consumer Discretionary
  • Exchange
  • EXEL Nasdaq
  • WPP Nasdaq
  • Market Cap
  • EXEL 9.8B
  • WPP 8.4B
  • IPO Year
  • EXEL 2000
  • WPP N/A
  • Fundamental
  • Price
  • EXEL $43.04
  • WPP $40.38
  • Analyst Decision
  • EXEL Buy
  • WPP Hold
  • Analyst Count
  • EXEL 18
  • WPP 1
  • Target Price
  • EXEL $38.76
  • WPP N/A
  • AVG Volume (30 Days)
  • EXEL 3.9M
  • WPP 268.0K
  • Earning Date
  • EXEL 05-13-2025
  • WPP 02-27-2025
  • Dividend Yield
  • EXEL N/A
  • WPP 6.17%
  • EPS Growth
  • EXEL 237.58
  • WPP 389.11
  • EPS
  • EXEL 2.20
  • WPP 0.62
  • Revenue
  • EXEL $2,298,922,000.00
  • WPP $18,454,623,978.00
  • Revenue This Year
  • EXEL $10.39
  • WPP N/A
  • Revenue Next Year
  • EXEL $10.74
  • WPP $1.46
  • P/E Ratio
  • EXEL $19.53
  • WPP $12.77
  • Revenue Growth
  • EXEL 24.49
  • WPP N/A
  • 52 Week Low
  • EXEL $20.40
  • WPP $31.52
  • 52 Week High
  • EXEL $48.85
  • WPP $57.37
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 59.93
  • WPP 57.69
  • Support Level
  • EXEL $42.21
  • WPP $40.10
  • Resistance Level
  • EXEL $43.75
  • WPP $40.71
  • Average True Range (ATR)
  • EXEL 1.60
  • WPP 0.51
  • MACD
  • EXEL -0.09
  • WPP 0.00
  • Stochastic Oscillator
  • EXEL 53.96
  • WPP 62.00

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About WPP WPP plc

Headquartered in the United Kingdom, WPP is one of the world's largest ad holding companies based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.

Share on Social Networks: